MNBTD
TGTX icon

Moody National Bank Trust Division’s TG Therapeutics TGTX Stock Holding History

Moody National Bank Trust Division’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-84,149
Closed -$1.33M – 249
2014
Q4 		$1.33M Buy
+84,149
New +$1.1M 0.09% 52

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Moody National Bank Trust Division's TGTX Position: Q1 2015 in Review

Moody National Bank Trust Division sold out of TG Therapeutics (TGTX) in Q1 2015, closing a stake of 84,149 shares — an estimated $1.33M sold.

Moody National Bank Trust Division first reported a position in TGTX in Q4 2014 and held it in 1 quarter. The position peaked at $1.33M in Q4 2014. 79 funds tracked by Wall St. Rank hold TGTX as of Q1 2015.

  • Moody National Bank Trust Division reported no remaining TG Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Moody National Bank Trust Division sold 84,149 TG Therapeutics shares in Q1 2015, an estimated $1.33M.
  • Moody National Bank Trust Division first reported a position in TG Therapeutics in Q4 2014 and held it in 1 quarter.
  • Moody National Bank Trust Division's TG Therapeutics position peaked at $1.33M in Q4 2014.
  • 79 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2015.

Based on Moody National Bank Trust Division's 13F filing for Q1 2015, filed 13 May 2015.